Associate in EthiopiaMaisha Meds
Maisha Meds is hiring! We’re looking for an Associate with a background in public health, supply chain, pharmacy and/or pharmaceutical drug sales to support the implementation of our project in Ethiopia.
About the role
We are looking for an enthusiastic professional to support the implementation of our project in Ethiopia. The ideal candidate enjoys a fast-paced working environment, loves working with and interacting with customers, and is passionate about improving access to healthcare in rural Ethiopia.
The role is based in Addis Ababa with frequent travel to Oromia and Amhara. You will report to the Country Manager for this work and will supervise 2-4 field team members.
Maisha Meds reserves the right to adapt the work scope for the employee, in response to company needs or changes in direction.
Why You Should Join Us
Maisha Meds aims to leverage technology to solve problems that affect millions of people across sub-Saharan Africa. We can promise you an opportunity to drive real, quantifiable change that literally saves lives. We are dedicated to our work and care deeply about our product’s impact. You’ll join our small and friendly team to grow Maisha Meds into a company serving tens of millions of people across East Africa.
Start date is in February, and compensation is commensurate with experience.
Open to Ethiopian applicants only.
About Maisha Meds
Maisha Meds is an organisation dedicated to improving health care in Africa. We began full-time operations in 2017 and over the past few years has grown to support over 4 million patient encounters at over 1,200 pharmacies and drug shops annually across Kenya, Tanzania, Uganda, Nigeria, and Zambia. We are building the financial and technology infrastructure to enable global health funders to pay for health outcomes at the last mile, with an initial focus on malaria case management. Recent results from a randomised controlled trial with UC Berkeley showed that our programs lead to a statistically significant 350% increase in appropriate and high quality malaria care. Based on these results, we are planning to scale the technology to reach over 10,000 health facilities and 20 million patients, and to directly pay for health outcomes for 1 million patients annually by 2024. In addition, we are actively building programs to support injectable contraceptives, HIV pre-exposure prophylaxis, measles and HPV vaccines, malnutrition support, and safe water interventions.
Our work is funded by USAID Development Innovation Ventures, the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, Grand Challenges Canada, Pfizer, and others, and we are starting to build partnerships with multilateral global health funders, pharmaceutical companies, and national health insurance funds to have them pay us on a contract basis for health outcomes. We use data from our point of sale software to design programs that leverage financial incentives to improve uptake of high impact health products. And we measure our success by our ability to improve the quality and affordability of healthcare diagnosis, treatment, and prevention for low-income patients across Africa.